SCHEMBL5504534

SCHEMBL5504534

CCC(Oc1c(C#N)cnc2ccc(I)cc12)C(C)I

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRC P12931 9/20 0.38
LRRK2 Q5S007 1/20 0.35
PRKDC P78527 3/20 0.32
KDR P35968 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
GSK3B P49841 1/20 0.32
KCNH2 Q12809 1/20 0.32
ATM Q13315 1/20 0.32
ATR Q13535 1/20 0.32
ABCB1 P08183 1/20 0.32
ABCC1 P33527 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
EGFR P00533 7/20 0.31
ERBB2 P04626 4/20 0.31
RAF1 P04049 1/20 0.31
MAP2K1 Q02750 1/20 0.31
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3884874 0.86 SRC (0.38) SRCLRRK2PRKDCKDRPIK3CA
SCHEMBL5507082 0.85 SRC (0.35) SRCLRRK2PRKDCKDRPIK3CA
SCHEMBL13955657 0.84 SRC (0.44) SRCLRRK2PRKDCABCB1ABCC1
SCHEMBL3887019 0.80 SRC (0.43) SRCLRRK2EGFRERBB2RAF1
SCHEMBL3883564 0.80 SRC (0.39) SRCLRRK2PRKDCABCB1ABCC1
SCHEMBL3896435 0.77 SRC (0.42) SRCLRRK2EGFRRAF1MAP2K1
SCHEMBL3880256 0.76 GABRA1 (0.36) SRCLRRK2PRKDCABCB1ABCC1
SCHEMBL3879099 0.75 SRC (0.43) SRCKDREGFRERBB2RAF1
SCHEMBL3882562 0.75 SRC (0.39) SRCLRRK2PRKDCEGFRERBB2
SCHEMBL3891687 0.72 GABRA1 (0.37) SRCABCB1ABCC1ABCG2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771443-A1 QUINOLINE THIAZOLINONES WITH CDK1 ANTIPROLIFERATIVE ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2007-04-11 EP disclosed
WO-2006002828-A1 QUINOLINE THIAZOLINONES WITH CDK1 ANTIPROLIFERATIVE ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2006-01-12 WO disclosed